“On Dec. 14, the Lancet together with the Institute for Health Metrics and Evaluation [IHME] will release their study on global burden of disease, injuries and risk factors in 2010,” Karl Hofmann, president and CEO of Population Services International, writes in a Devex opinion piece, adding, “These ‘gold standard’ data will quantify the world’s health problems by examining statistics for 291 diseases and injuries and 67 different risk factors for 21 regions across three time periods — 1990, 2005 and 2010.” Hofmann says, “The new health burden data are reference points for the units of currency that help us measure our impact, such as on the years of protection against unintended pregnancy, episodes of disease prevented, deaths averted, and years of healthy life saved, among many others.” He adds, “As global health implementers, it is important that these metrics inform our work, define our impact and demonstrate our value to donors, and more importantly, to those we serve.”
Programs, Funding & Financing
On the U.S. Global Leadership Coalition (USGLC) blog, Ashley Chandler, deputy policy director at the USGLC, discusses USAID’s new guidance on Building Resilience to Recurrent Crisis, writing that the policy “is about using existing development dollars more effectively in disaster prone regions, so that less humanitarian assistance is needed in the future.” She asks, “But what’s the ultimate goal?” and continues, “USAID Administrator Rajiv Shah says success will be measured by whether USAID is able ‘to put ourselves out of business’ by reducing the number, volume, and length of time of the ‘infusions of humanitarian assistance needed in the future.'” Chandler concludes, “As America strives to get our own fiscal house in order, the fact of the matter is that we’re also nearing a critical mass for relief and development funding. Meaning, ‘doing more of the same,’ to quote Administrator Shah, is no longer an option. Nor should it be” (12/12).
IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, “One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut.” According to the news service, “The Global Fund stopped most of its funding to the Secretriado National de Luta Contra le Sida (SNLS), the government structure in charge of coordinating the HIV response, at the end of 2011, because of poor performance management and a lack of transparent fiduciary controls.”
“United Nations member states pledged $384 million on Tuesday to an emergency fund that will allow the world body to respond quickly to natural disasters and other crises in 2013, U.N. aid chief Valerie Amos said,” Reuters reports. “The U.N. Central Emergency Response Fund (CERF) … has raised more than $2.8 billion since it was launched in 2006,” and “[s]o far in 2012, the fund has allocated $465 million for humanitarian aid in 49 countries, including Myanmar, South Sudan, Syria, North Korea, Haiti and Pakistan,” the news agency notes (12/11). At a high-level conference on the CERF, U.N. Secretary-General Ban Ki-moon said, “From flood zones to war zones, CERF stops crises from turning into catastrophes. … The Fund does this through quick, targeted support when an emergency starts or by injecting funds in stubbornly under-funded situations,” according to the U.N. News Centre. “The rapid and flexible support offered by the CERF makes it a central pillar of the U.N. agencies’ humanitarian response,” Amos said at the conference, the news service notes (12/11).
“African scientists from key research institutions and universities have challenged governments to take serious the issues of neglected and tropical disease to curb millions of deaths among the poor,” Xinhua reports. More than 50 researchers met this week in Kisumu, Kenya, at the 6th Annual Neglected Tropical Diseases (NTDs) Symposium, where they “said action is needed from the government, donors, and drug companies to reduce death associated with NTDs,” the news service writes. “The researchers said even with massive deaths associated with NTDs, challenges remain in reaching those affected,” as the diseases are “perceived to only affect the poor who are regarded as less important in the society” and do not have the ability to purchase treatments, Xinhua adds, and writes, “The meeting was centered on the theme making elimination feasible, [and] ‘neglect no more’ in line with [Kenya Medical Research Institute] efforts to control the effects of neglected tropical diseases in the region” (12/11).
Noting “[m]ultidrug-resistant organisms are showing up in top-flight hospitals” around the world, Carl Nathan, chair of the department of microbiology and immunology at Weill Cornell Medical College, writes in this New York Times opinion piece, “What makes the rapid loss of antibiotics to drug resistance particularly alarming is that we are failing to make new ones.” He continues, “We are emptying our medicine chest of the most important class of medicines we ever had. And the cause can be traced, for the most part, to two profound problems.”
“British mobile phone group Vodafone and drug maker GlaxoSmithKline are joining forces on a novel project to increase childhood vaccination rates in Mozambique using text messaging,” Reuters reports. With the aim of increasing the proportion of children covered by vaccination by five to 10 percent, a one-year pilot project supported by Save the Children “will register mothers on a ministry of health database, alert them to the availability of vaccinations and allow them to schedule appointments by text,” the news agency notes. In addition, a three-year partnership between Vodafone and the GAVI Alliance, supported by the British government, will “study how health ministries across sub-Saharan Africa can use mobile technology to improve their immunization programs,” Reuters notes, adding, “Britain will match Vodafone’s contribution of technology and services with a $1.5 million cash contribution to GAVI” (12/10).
“In an effort to fight the human papillomavirus (HPV), the leading cause of cervical cancer, more than 30 million girls will be immunized against HPV by 2020 with GAVI support, the global health alliance announced on Thursday,” Xinhua/Global Times reports. “Rwanda and Uganda have been conducting HPV pilot projects through donations from vaccine manufacturers and are expected to roll out the vaccine nationwide with GAVI support in 2014,” the news service writes, adding, “By 2015, GAVI plans to immunize approximately one million girls with HPV vaccines and a large number of other countries are expected to run HPV pilot projects, and by 2020, more than 30 million girls will be immunized against HPV, [GAVI Alliance CEO Seth] Berkley said” (12/7).
“There is currently a $3.6 billion funding gap on malaria in Africa, according to the Roll Back Malaria Partnership, whose board concluded its 23rd meeting in Dakar, Senegal, on December 7,” Devex’s “Development Newswire” blog reports. Of the total, eight African countries — Nigeria, Central African Republic, Cote d’Ivoire, Democratic Republic of the Congo, Ethiopia, Mauritania, Niger, and Sierra Leone — need $2.4 billion to maintain their malaria prevention and treatment efforts over the next two years, “with Nigeria alone requiring nearly half that amount,” according to the blog (Ravelo, 12/10).
“After three decades of global emergency responses and a series of scientific breakthroughs in the fight against HIV/AIDS, it is now tempting to ask if we are marching towards the end of AIDS,” an editorial in the Lancet states. Noting the November 29 release of the U.S. Government’s PEPFAR Blueprint: Creating an AIDS-Free Generation, the Lancet writes, “The first and foremost signal the report has sent is that the U.S. commitment to the global AIDS response will continue to be ‘strong, comprehensive and driven by science,'” and the report “calls on partner countries, civil society, donors, foundations, multilateral institutions, and people living with HIV to step up together and make concrete commitments.” The editorial continues, “The vision of ‘an AIDS-free generation’ in the blueprint relies heavily on scientific and technological feasibility … However, eradicating a disease goes far beyond scientific advances, which will go unrealized without strong social support and public health actions as well as substantial and sustainable investments.”